Canada’s chief public health officer Dr. Theresa Tam said Sunday the rapid test developed by Ottawa-based biotech company Spartan Bioscience for COVID-19 “did not perform well” in a clinical setting, despite earlier results which appeared promising, adding the failures were believed to be related to the test’s proprietary swab.
Canada
Coronavirus outbreak: Tam says Spartan rapid test for COVID-19 ‘didn’t perform well’ in clinical setting
More Videos
-
Montreal police’s racial profiling a ‘systemic problem,’ Quebec judge rules
-
Poilievre calls for ‘sellout Singh’ to trigger ‘carbon tax election’ after NDP pulls Liberal support
-
Is Canada headed for an election? What comes next after NDP ‘rips up’ deal with Liberals?
-
Bigger cuts a possibility as Bank of Canada lowers benchmark interest rate to 4.25%
-
Jagmeet Singh says NDP has ‘ripped up’ supply and confidence agreement with the Liberals
-
Business Matters: Kids feeling impacts of Canada’s cost of living crunch, poll finds
You are viewing an Accelerated Mobile Webpage.
View Original Article